Thymosin Injection

Trade Name: ThymoCure
Available Strength : 1.6 mg
Available Combination : Thymosin Injection is a combination of immune-modulating peptides used to enhance T-cell function, strengthen immune response, and support recovery in immunocompromised conditions.
Packing : vial
Pack Insert/Leaflet : YES
Therapeutic use : Thymosin Injection is an immunomodulatory agent used to enhance and regulate immune function. It is commonly prescribed in conditions involving immune deficiency, recurrent infections, chronic viral infections, and as an adjunct therapy in cancer and autoimmune disorders, where it helps improve T-cell activity and overall immune response.
Capacity : 100000

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.